Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen

Abstract
Endocrine factors may affect the clinical course of malignant melanoma and the response to the treatment of this disease. The presence of estrogen receptors in melanomas has been suggested, and occasional responses to antiestrogen therapy have been reported.

This publication has 41 references indexed in Scilit: